EFFECTIVENESS OF HIV PRE-EXPOSURE PROPHYLAXIS FOR PREVENTION OF HIV: A RETROSPECTIVE COHORT ANALYSIS

被引:0
|
作者
Song, H. J. [1 ]
Squires, P. [2 ]
Cook, R. L. [3 ]
Park, H. [4 ]
机构
[1] Univ Florida, Coll Pharm, Suwon, South Korea
[2] Univ Florida, Coll Pharm, Gainesville, FL USA
[3] Univ Florida, SHARC Ctr Translat HIV Res, Gainesville, FL USA
[4] Univ Florida, Coll Pharm, Gainesville, FL USA
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
EPH84
引用
收藏
页码:S450 / S450
页数:1
相关论文
共 50 条
  • [21] HIV Prevention: The Promise of Pre-Exposure Prophylaxis in Singapore
    Wong, Chen Seong
    [J]. ANNALS ACADEMY OF MEDICINE SINGAPORE, 2017, 46 (07) : 265 - 266
  • [22] HIV: Pre-exposure Prophylaxis
    Singh, Ajai Kumar
    Singh, Ashish
    Singh, Deepti
    Singh, Manish
    Singh, Pratibha
    Sharma, Abhishek
    [J]. INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2012, 3 (12) : 900 - 901
  • [23] HIV pre-exposure prophylaxis
    Fougere, Edouard
    [J]. ACTUALITES PHARMACEUTIQUES, 2024, 63 (638): : 14 - 16
  • [24] HIV pre-exposure prophylaxis
    Morin, Stephen F.
    Yamey, Gavin
    Rutherford, George W.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2012, 345
  • [25] Cost-effectiveness analysis of HIV pre-exposure prophylaxis in Japan
    Mizushima, Daisuke
    Nagai, Yoshino
    Mezzio, Dylan
    Harada, Keisuke
    Piao, Yi
    Barnieh, Lianne
    El Moustaid, Fadoua
    Cawson, Matthew
    Taniguchi, Toshibumi
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 886 - 893
  • [26] HIV pre-exposure prophylaxis (PrEP): Is it time to rethink HIV prevention in travelers?
    Hampel, Benjamin
    Reinacher, Matthias
    Fehr, Jan S.
    [J]. TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2018, 25 : 6 - 7
  • [27] Cost-effectiveness of the dual prevention pill for contraception and HIV pre-exposure prophylaxis
    Milali, Masabho P.
    Resar, Danielle
    Kaftan, David
    Campbell, Jennifer
    Olowu, Adebanjo
    Edwards, Danny
    Platais, Ingrida
    Kim, Hae-Young
    Jenkins, Sarah
    Bershteyn, Anna
    [J]. FRONTIERS IN REPRODUCTIVE HEALTH, 2023, 5
  • [28] SYSTEMATIC REVIEW OF COST-EFFECTIVENESS: PRE-EXPOSURE PROPHYLAXIS (PREP) FOR THE PREVENTION OF HIV
    Marshall, L.
    Teljeur, C.
    Murchu, E. O.
    Harrington, P.
    Ryan, M.
    [J]. VALUE IN HEALTH, 2019, 22 : S659 - S659
  • [29] Missed opportunities of HIV pre-exposure prophylaxis in France: a retrospective analysis in the French DAT'AIDS cohort
    Lions, C.
    Cabras, O.
    Cotte, L.
    Huleux, T.
    Gagneux-Brugnon, A.
    Makinson, A.
    Cabie, A.
    Bonnet, B.
    Duvivier, C.
    Hocqueloux, L.
    Cua, E.
    Cheret, A.
    Hustache-Mathieu, L.
    Obry-Roguet, V.
    Jacomet, C.
    Poizot-Martin, I.
    Drobacheff-Thiebaut, C.
    Foltzer, A.
    Bouiller, K.
    Chirouze, C.
    Lepiller, Q.
    Bozon, F.
    Babre, O.
    Muret, P.
    Laurichesse, H.
    Lesens, O.
    Vidal, M.
    Mrozek, N.
    Aumeran, C.
    Baud, O.
    Corbin, V.
    Letertre, P.
    Casanova, S.
    Prouteau, J.
    Hoen, B.
    Lamaury, I.
    Fabre, I.
    Curlier, E.
    Ouissa, R.
    Schepers, K.
    Herrmann-Storck, C.
    Dournon, N.
    Merrien, D.
    Perre, P.
    Guimard, T.
    Bollangier, O.
    Leautez, S.
    Morrier, M.
    Ader, F.
    Biron, F.
    [J]. BMC INFECTIOUS DISEASES, 2019, 19 (1)
  • [30] Missed opportunities of HIV pre-exposure prophylaxis in France: a retrospective analysis in the French DAT’AIDS cohort
    C. Lions
    O. Cabras
    L. Cotte
    T. Huleux
    A. Gagneux-Brugnon
    A. Makinson
    A. Cabié
    B. Bonnet
    C. Duvivier
    L. Hocqueloux
    E. Cua
    A. Cheret
    L. Hustache-Mathieu
    V. Obry-Roguet
    C. Jacomet
    I. Poizot-Martin
    [J]. BMC Infectious Diseases, 19